SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality

Cell

Volumn 98, Issue 5, 1999, Pages 609-616

  Marine, Jean Christophe ^a   Topham, David J ^a   McKay, Catriona ^a   Wang, Demin ^a   Parganas, Evan ^a   Stravopodis, Dimitrios ^a   Yoshimura, Akihiko ^c   Ihle, James N ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ARTICLE; CYTOKINE PRODUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PERINATAL MORBIDITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALIA;

EID: 0033520467     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80048-3     Document Type: Article

References (26)

1. Adams, I.E., Hansen, J.A., Starr, R., Nicola, N.A., Hilton, D.J., and Billestrup, N. (1998). Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273, 1285-1287.
2. Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular responses to Interferon γ. Annu. Rev. Immunol. 15, 749-795.
3. Bunting, K.D., Sangster, M.Y., Ihle, J.N., and Sorrentino, B.P. (1998). Restoration of lymphocyte function in Janus kinase 3-def icient mice by retroviral-mediated gene transfer. Nat. Med. 4, 58-64.
4. Endo, T.A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997). A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387, 921-924.
5. Gresser, L, Aguet, M., Morel-Maroger, L, Woodrow, D., Puvion-Dutilleul, F., Guillon, J-C., and Maury, C. (1981) Electrophoretically pure mouse Interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am. J. Pathol. 102, 396-402.
6. Hettmann, T., DiDonato, J., Karin, M., and Leiden, J.M. (1999). An essential role for nuclear factor KB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189, 145-158.
7. Hilton, D.J., Richardson, R.T., Alexander, W.S., Viney, E.M., Willson, T.A., Sprigg, N.S., Starr, R., Nicholson, S.E., Metcalf, D., and Nicola, N.A. (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95, 114-119.
8. Lerner, A., Clayton, L.K., Mizoguchi, E., Ghendler, Y., van Ewijk, W., Koyasu, S., Bhan, A.K., and Reinherz, E.L. (1996). Cross-linking of T-cell receptors on double-positive thymocytes induces a cytokine-mediated stromal activation process linked to cell death. EMBO J. 15, 5876-5887.
9. Mattsson, Ft., Mattsson, A., Holmdahl, Ft., Scheynius, A., and van der Meide, P.M. (1992). In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues. Biol. Reprod. 46, 1176-1186.
10. Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., Akira, S., and Kishimoto, T. (1997). Structure and function of a new STAT-induced STAT inhibitor. Nature 387, 924-929.
11. Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y., Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., and Kishimoto, T. (1998). Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95, 15577-15582.
12. Nosaka, T., van Deursen, J.M.A., Tripp, R.A., Thierfelder, W.E., Witthuhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1995). Defective lymphoid development in mice lacking Jak3. Science 270, 800-802.
13. Okamoto, T., Furuya, M., Yamakawa, T., Yamamura, K., and Hino, O. (1996). TNFα gene expression in the liver of IFNγ transgenic mouse with chronic active hepatitis. Biochem. Biophys. Commun. 226, 762-768.
14. Parganas, E., Wang, D., Stravopodis, D.,Topham, D.U., Marine, J.-C., Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen, U.M., et al. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395.
15. Rodig, S.u., Meraz, M .A., White, J.M., Lampe, P.A., Riley, U.K., Arthur, C., King, K.L., Sheehan, K.C.F., Yin, L, Pennica, D., et al. (1998). Targeted disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of Janus kinases in mediating cytokine induced biologic responses. Cell 93, 373-383.
16. Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., et al. (1998). A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92, 1668-1676.
17. Shi, Y.F., Bissonnette, R.P., Parfrey, N., Szalay, M., Kubo, R.T., and Green, D.R. (1991). In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146, 3340-3346.
18. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A., and Hilton, D.J. (1997). A family of cytokine-inducible inhibitors of signaling. Nature 387, 917-921.
19. Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola, N.A., Hilton, D.J., and Alexander, W.S. (1998). Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sei. USA 95, 14395-14399.
20. - double-negative thymocytes. J. Immunol. 144, 3039-3045.
21. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.M., and Berg, L.J. (1995). Mice lacking JakS have defects in B lymphocyte maturation and T lymphocyte activation. Science 270, 794-797.
22. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
23. Toyonaga, T., Hino, O., Sugai, S., Wakasugi, S., Abe, K., Shichiri, M., and Yamamura, K. (1994). Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc. Natl. Acad. Sei. USA 97, 614-618.
24. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., and Yoshimura, A. (1999). The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EM BO J. 18, 1309-1320.
25. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N.A., Gilbert, D.J., Copeland, N.G., Hara, T., and Miyajima, A. (1995). A novel cytokineinducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin-3 and erythropoietin receptors. EM BO J. 14, 2816-2826.
26. Young, H.A., Klinman, D.M., Reynolds, D.A., Grzegorzewski, K.J., Nil, A., Ward, J.M., Winkler-Pickett, R.T., Ortaldo, J.R., Kenny, J.J., and Kamschlies, K.L. (1997). Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 89, 583-595.